Risk Factor | n | Percentage from each group that sustained a HSI | RR (95% CI) | p Value |
---|---|---|---|---|
Passive fascicle length | 152 | |||
<10.56 cm | 56 | 33.9 | 4.1 (1.9 to 8.7) | 0.001** |
≥10.56 cm | 96 | 8.3 | ||
Passive fascicle length relative to BFlh length | 152 | |||
<0.254 | 38 | 39.4 | 3.7 (1.9 to 7.3) | 0.001** |
≥0.254 | 114 | 10.5 | ||
25% MVIC fascicle length | 141 | |||
<9.61 cm | 79 | 25.3 | 3.2 (1.2 to 7.9) | 0.008* |
≥9.61 cm | 62 | 8.0 | ||
Passive fascicle length imbalance | 152 | |||
<10% imbalance | 80 | 16.3 | 1.2 (0.6 to 2.4) | 0.673 |
≥10% imbalance | 72 | 19.4 | ||
<15% imbalance | 99 | 15.1 | 1.5 (0.7 to 3.0) | 0.271 |
≥15% imbalance | 53 | 22.6 | ||
<20% imbalance | 125 | 16.8 | 1.3 (0.6 to 3.0) | 0.579 |
≥20% imbalance | 27 | 22.2 | ||
25% MVIC fascicle length imbalance | 141 | |||
<10% imbalance | 78 | 20.0 | 1.3 (0.6 to 2.6) | 0.512 |
≥10% imbalance | 63 | 20.6 | ||
<15% imbalance | 100 | 22.7 | 0.7 (0.3 to 1.7) | 0.630 |
≥15% imbalance | 41 | 14.6 | ||
<20% imbalance | 118 | 22.0 | 0.4 (0.1 to 1.7) | 0.249 |
≥20% imbalance | 23 | 8.7 | ||
Passive muscle thickness | 152 | |||
<2.35 cm | 36 | 11.1 | 0.56 (0.2 to 1.5) | 0.320 |
≥2.35 cm | 116 | 19.8 | ||
25% MVIC muscle thickness | 141 | |||
<2.61 cm | 58 | 20.6 | 1.3 (0.6 to 2.7) | 0.504 |
≥2.61 cm | 83 | 15.6 | ||
Eccentric strength | 131 | |||
<337 N | 96 | 25.0 | 4.4 (1.1 to 17.5) | 0.013* |
≥337 N | 35 | 5.7 | ||
<145 Nm | 89 | 25.8 | 3.6 (1.2 to 11.4) | 0.017* |
≥145 Nm | 42 | 7.1 | ||
<4.35 N/kg | 82 | 25.6 | 2.5 (1.1 to 6.2) | 0.041* |
≥4.35 N/kg | 49 | 10.0 | ||
<1.86 Nm/kg | 78 | 26.9 | 2.9 (1.1 to 7.1) | 0.011* |
≥1.86 Nm/kg | 53 | 9.4 | ||
Eccentric strength imbalance | 131 | |||
<10% imbalance | 76 | 19.7 | 1.0 (0.5 to 2.0) | 1.000 |
≥10% imbalance | 55 | 20.0 | ||
<15% imbalance | 98 | 18.3 | 1.3 (0.6 to 2.7) | 0.459 |
≥15% imbalance | 33 | 24.2 | ||
<20% imbalance | 117 | 18.8 | 1.5 (0.6 to 3.8) | 0.476 |
≥20% imbalance | 14 | 28.5 | ||
MVIC strength | 141 | |||
<400 N | 93 | 21.5 | 2.0 (0.8 to 5.2) | 0.161 |
≥400 N | 48 | 10.4 | ||
<172 Nm | 88 | 20.4 | 1.5 (0.7 to 3.5) | 0.364 |
≥172 Nm | 53 | 13.2 | ||
<4.60 N/kg | 52 | 23.1 | 1.5 (0.7 to 3.2) | 0.254 |
≥4.60 N/kg | 89 | 14.6 | ||
<2.07 Nm/kg | 62 | 22.6 | 1.6 (0.8 to 3.3) | 0.192 |
≥2.07 Nm/kg | 79 | 13.9 | ||
MVIC strength imbalance | 141 | |||
<10% imbalance | 81 | 19.7 | 0.8 (0.4 to 1.8) | 0.826 |
≥10% imbalance | 60 | 16.6 | ||
<15% imbalance | 110 | 16.3 | 1.3 (0.6 to 2.9) | 0.434 |
≥15% imbalance | 31 | 22.6 | ||
<20% imbalance | 126 | 17.4 | 1.1 (0.4 to 3.3) | 0.732 |
≥20% imbalance | 15 | 20.0 | ||
Prior injury | 152 | |||
HSI | 30 | 30.0 | 2.0 (1.0 to 4.0) | 0.063 |
No HSI | 122 | 14.7 | ||
ACL | 16 | 31.1 | 1.9 (0.8 to 4.4) | 0.164 |
No ACL | 136 | 16.1 | ||
Calf strain | 13 | 23.1 | 1.3 (0.4 to 3.8) | 0.713 |
No calf strain | 139 | 17.3 | ||
Quadriceps strain | 21 | 28.6 | 1.8 (0.8 to 3.9) | 0.215 |
No Quadriceps strain | 131 | 16.0 | ||
Chronic groin pain | 13 | 23.1 | 1.3 (0.5 to 3.8) | 0.703 |
No chronic groin pain | 139 | 17.3 | ||
Age (years) | 152 | |||
≤18.0 | 8 | 12.5 | 1.5 (0.2 to 9.7) | 1.000 |
>18.0 | 144 | 18.7 | ||
≤20.4 | 37 | 2.7 | 8.4 (1.1 to 59.5) | 0.005* |
>20.4 | 115 | 22.6 | ||
≤23.7 | 74 | 6.7 | 4.2 (1.6 to 10.4) | 0.001* |
>23.7 | 78 | 28.2 | ||
≤28.8 | 116 | 13.8 | 2.2 (1.1 to 4.3) | 0.043* |
>28.8 | 36 | 30.5 | ||
≤32.6 | 136 | 12.5 | 0.7 (0.2 to 2.6) | 0.739 |
>32.6 | 16 | 18.4 | ||
Height (cm) | ||||
≤182.3 | 111 | 15.3 | 1.6 (0.8 to 3.4) | 0.206 |
>182.3 | 41 | 24.4 | ||
Weight (kg) | ||||
≤77.9 | 102 | 15.7 | 1.4 (0.7 to 2.8) | 0.370 |
>77.9 | 50 | 22.0 |
*=p<0.05, **=p<0.001 when comparing the RR of future HSI between groups.ACL, anterior cruciate ligament; BFlh, biceps femoris long head; Cm, centimetres; HSI, hamstring strain injury; Kg, kilogram; MVIC, maximal voluntary isometric contraction; N/Kg, Newtons per kilogram of body weight; N, Newtons; Nm/kg, Newton metres per kilogram of body weight; Nm, Newton metres; RR, relative risk.